Table 1. Demographic, MRI findings and clinical information for each patient.
Patient | Gender | Age (years) | Medications (mg/day) | MRI findings | SEEG | ||||
Side | Sample lobes | Neocortex* | Hippocampus* | Epileptogenic Zone** | |||||
1 | M | 40 | Carbamazepine (800) | Unrevealing | Left | FT | Superior F gyrus | Left Anterior-Central | Middle F gyrus |
Topiramate (300) | |||||||||
2 | F | 27 | Carbamazepine (1600) Vigabatrin (3000) Levetiracetam (3000) | Right O cortical dysplasia | Right | TPO | Supramarginal gyrus | Right Central-Posterior | TO basal junction |
3 | M | 43 | Oxcarbazepine (1500) Topiramate (600) Clonazepam (1.5) | Right C-T-P polymicrogyria | Right | FCPT | Inferior F gyrus | Right Posterior | First T gyrus |
4 | F | 34 | Carbamazepine (1200) Levetiracetam (3000) Phenobarbital (100) | Left P-O ischemic lesion | Left | TOP | Secod T gyrus | Left Posterior | Fusiform gyrus |
5 | F | 35 | Oxcarbazepine (1200) Barbexaclone (100) Topiramate (400) | Left T-O periventricular heterotopia | Left | TOPC | Supramarginal Gyrus | Left Central-Posterior | P cingulated gyrus |
C = central; F = frontal; O = occipital; P = parietal; T = temporal.
Indicates the position of the SEEG derivations submitted to sleep EEG analysis.
Indicate the site of origin of the seizures.